State Street’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Sell |
1,019,774
-260,677
| -20% | -$3.39M | ﹤0.01% | 2425 |
|
|
2025
Q1 | $13.6M | Sell |
1,280,451
-45,707
| -3% | -$484K | ﹤0.01% | 2338 |
|
|
2024
Q4 | $22.5M | Sell |
1,326,158
-146,797
| -10% | -$2.49M | ﹤0.01% | 2165 |
|
|
2024
Q3 | $34.2M | Sell |
1,472,955
-50,883
| -3% | -$1.18M | ﹤0.01% | 1894 |
|
|
2024
Q2 | $37.1M | Sell |
1,523,838
-436,098
| -22% | -$10.6M | ﹤0.01% | 1815 |
|
|
2024
Q1 | $66.2M | Buy |
1,959,936
+330,270
| +20% | +$11.2M | ﹤0.01% | 1564 |
|
|
2023
Q4 | $51.4M | Sell |
1,629,666
-38,259
| -2% | -$1.21M | ﹤0.01% | 1691 |
|
|
2023
Q3 | $42.6M | Sell |
1,667,925
-316,243
| -16% | -$8.08M | ﹤0.01% | 1718 |
|
|
2023
Q2 | $56.9M | Sell |
1,984,168
-253,831
| -11% | -$7.28M | ﹤0.01% | 1590 |
|
|
2023
Q1 | $53.6M | Sell |
2,237,999
-19,847
| -0.9% | -$476K | ﹤0.01% | 1616 |
|
|
2022
Q4 | $38.3M | Sell |
2,257,846
-472,616
| -17% | -$8.02M | ﹤0.01% | 1821 |
|
|
2022
Q3 | $40.5M | Sell |
2,730,462
-76,456
| -3% | -$1.13M | ﹤0.01% | 1752 |
|
|
2022
Q2 | $44.2M | Sell |
2,806,918
-411,039
| -13% | -$6.47M | ﹤0.01% | 1732 |
|
|
2022
Q1 | $86.8M | Buy |
3,217,957
+1,161,883
| +57% | +$31.3M | ﹤0.01% | 1393 |
|
|
2021
Q4 | $76.1M | Buy |
2,056,074
+585,733
| +40% | +$21.7M | ﹤0.01% | 1518 |
|
|
2021
Q3 | $70.3M | Sell |
1,470,341
-285,313
| -16% | -$13.6M | ﹤0.01% | 1548 |
|
|
2021
Q2 | $59.4M | Buy |
1,755,654
+357,619
| +26% | +$12.1M | ﹤0.01% | 1718 |
|
|
2021
Q1 | $57.7M | Buy |
1,398,035
+386,116
| +38% | +$15.9M | ﹤0.01% | 1633 |
|
|
2020
Q4 | $43.9M | Sell |
1,011,919
-548,335
| -35% | -$23.8M | ﹤0.01% | 1719 |
|
|
2020
Q3 | $66.9M | Buy |
1,560,254
+1,302,232
| +505% | +$55.9M | ﹤0.01% | 1239 |
|
|
2020
Q2 | $12.1M | Buy |
+258,022
| New | +$12.1M | ﹤0.01% | 2317 |
|